RAGHAV CHARI, Executive Vice President, leads the Proprietary Products organization at Dr. Reddy's. He is responsible for developing a viable portfolio of products across the New Chemical Entities (NCE) and Differentiated Formulations businesses. Raghav joined Dr. Reddy's in 2006 as Vice President - Corporate Development for the NCE and Specialty business and has helped shape the company's Proprietary Products strategy while developing strong alliance platforms.
Raghav started his career with McKinsey and Company, where he spent several years as an Associate Engagement Manager and finally Associate Principal in McKinsey's Pharmaceuticals and Medical Products practice. After McKinsey, he took leadership roles in strategy and business development with several smaller biotech companies, most recently at NPS Pharmaceuticals.
Raghav is a graduate in Mathematics and Physics from the California Institute of Technology and holds a PhD in Theoretical Physics from Princeton University.
Raghav believes that the mission of Promius and Dr. Reddy's is to truly have an impact on patients' well being through the introduction of both innovative and affordable solutions for their medical challenges. "In the long run, we want to transform the nature of care for key conditions managed by dermatologists and podiatrists. Our research and development efforts are aligned against this long-term objective."
Dr. Chari credits his background in physics with enabling him to approach difficult problems unhindered by preconceptions. "I have always been interested in biology, economics, mathematical modeling, and systems behavior, and my educational background has provided me tools to integrate perspectives across these intersecting areas and apply them to our business."